Clinical trial
Fexofenadine in Pruritic Skin Disease
NCT00261079 · Handok Inc., Industry · Completed
Key facts
| NCT number | NCT00261079 |
|---|---|
| Title | Fexofenadine in Pruritic Skin Disease |
| Official title | The Evaluation of Efficacy and Safety of Fexofenadine 180mg Tablets for 7 Days in the Treatment of Pruritic Skin Disease |
| Lead sponsor | Handok Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pruritus |
| Intervention type | Drug |
| Interventions | Fexofenadine |
| Enrollment | 435 |
| Start date | Apr 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Dec 2, 2005 |
| Last update posted | Nov 7, 2007 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: